地佐辛超前应用对瑞芬太尼复合全身麻醉患者术后躁动的疗效分析

发布时间：2018-03-12 21:28

本文选题：地佐辛　切入点：瑞芬太尼　出处：《重庆医学》2016年05期 　论文类型：期刊论文

【摘要】：目的探讨地佐辛超前应用对瑞芬太尼复合全身麻醉(简称全麻)患者苏醒期躁动的临床疗效。方法选择在该院妇科行择期手术的子宫肌瘤患者92例,将其分为地佐辛组和对照组各46例,地佐辛组患者在手术全麻诱导前即静脉给予地佐辛,比较两组患者拔管后30min的平均动脉压(MAP)、心率(HR)、血氧饱和度(SpO2)、视觉疼痛评分(VAS)情况,并记录两组患者苏醒后60min内躁动发生频率和程度,对患者术后发生恶心呕吐、呼吸抑制等情况等进行对比分析。结果地佐辛组患者苏醒后躁动发生率为8.70%,低于对照组的43.48%(P0.05);地佐辛组术后不良反应发生率为6.52%,低于对照组的13.04%(P0.05)。结论超前应用地佐辛可有效减少瑞芬太尼复合全麻苏醒期躁动的发生率。
[Abstract]:Objective to investigate the clinical effect of preemptive application of dizosin in patients with restlessness during recovery from remifentanil combined with general anesthesia. Methods 92 patients with uterine leiomyoma undergoing elective gynecological surgery in our hospital were selected. The patients in the dizoxin group were given dizosin intravenously before general anesthesia induction. The mean arterial pressure (MAPP), heart rate (HR), oxygen saturation (SPO _ 2) and visual pain score (VASs) were compared between the two groups 30 minutes after extubation. The frequency and degree of restlessness and nausea and vomiting were recorded within 60 minutes after recovery. Results the incidence of restlessness in the dizoxin group was 8.70, which was lower than that in the control group (43.48) (P0.05), and the incidence of adverse reaction in the dizoxin group was 6.52, lower than that in the control group (13.04) (P 0.05). The incidence of restlessness during remifentanil combined with general anesthesia can be reduced effectively.
【作者单位】：哈励逊国际和平医院疼痛科;哈励逊国际和平医院麻醉科;
【基金】：衡水市科学技术局计划项目(13018z)
【分类号】：R614.2

【相似文献】